Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OSI Pharmaceuticals, a biotechnology company, has appointed Pierre Legault as its new executive vice president, CFO and treasurer. Mr Legault will assume the role on December 29, 2008.
Subscribe to our email newsletter
Mr Legault will succeed Michael Atieh who will be stepping down from the CFO position on December 29, 2008, pending his previously announced retirement which will now occur effective January 5, 2009.
Mr Legault was most recently at Rite Aid where he was senior executive vice president and chief administrative officer following his instrumental role in the 2007 merger of Eckerd into Rite Aid.
Mr Legault has over 16 years of senior management experience in the pharmaceutical industry including several senior positions at Sanofi-Aventis and Aventis, most notably worldwide president of Sanofi-Aventis Dermatology and senior vice president and CFO of Aventis Pharmaceutical North America.
According to the company, Mr Legault will add business and strategic expertise to the company’s leadership team and assume responsibility for all financial aspects of the company’s activities. Mr Legault will report to the CEO, Colin Goddard, and will be a leading member of OSI’s executive management team.
Dr Goddard said: “We are delighted that Pierre is joining the OSI team. Pierre has led finance and business teams in companies throughout the healthcare industry ranging from large pharma to major retail pharmacy chains and we are confident that, with his extensive financial and management experience, he will be a significant contributor to this company’s future growth and success.”